| Primary information |
|---|
| ID | 11657 |
| Uniprot ID | O95399 |
| Description | Urotensin-2 (Urotensin II) (U-II) (UII) |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the urotensin-2 family. |
| Tissue Specificity | Brain specific. |
| Post Translational Modification | NA |
| Function | Highly potent vasoconstrictor. |
| Length | 124 |
| Molecular Weight | 14 |
| Name | Urotensin-2 (Urotensin II) (U-II) (UII) |
| Sequence | ETPDCFWKYCV |
| Sequence map | 11 |
| PDB ID | 6HVB; 6HVC |
| Drugpedia | NA |
| Receptor | Q9UKP6 |
| Domain | NA |
| Pharmaceutical Use | NA
|